DE1470080A1 - 1-Niedrig-Alkyl-5-nitroimidazol-2-carboxamide,ein Verfahren zu ihrer Herstellung und ihre Verwendung als Heilmittel - Google Patents

1-Niedrig-Alkyl-5-nitroimidazol-2-carboxamide,ein Verfahren zu ihrer Herstellung und ihre Verwendung als Heilmittel

Info

Publication number
DE1470080A1
DE1470080A1 DE19641470080 DE1470080A DE1470080A1 DE 1470080 A1 DE1470080 A1 DE 1470080A1 DE 19641470080 DE19641470080 DE 19641470080 DE 1470080 A DE1470080 A DE 1470080A DE 1470080 A1 DE1470080 A1 DE 1470080A1
Authority
DE
Germany
Prior art keywords
alkyl
methyl
solution
nitroimidazole
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19641470080
Other languages
German (de)
English (en)
Inventor
Weston Henry David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1470080A1 publication Critical patent/DE1470080A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Basic Packing Technique (AREA)
DE19641470080 1963-08-07 1964-08-06 1-Niedrig-Alkyl-5-nitroimidazol-2-carboxamide,ein Verfahren zu ihrer Herstellung und ihre Verwendung als Heilmittel Pending DE1470080A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30067563A 1963-08-07 1963-08-07

Publications (1)

Publication Number Publication Date
DE1470080A1 true DE1470080A1 (de) 1970-01-02

Family

ID=23160128

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19641470080 Pending DE1470080A1 (de) 1963-08-07 1964-08-06 1-Niedrig-Alkyl-5-nitroimidazol-2-carboxamide,ein Verfahren zu ihrer Herstellung und ihre Verwendung als Heilmittel

Country Status (11)

Country Link
BE (1) BE651423A (enExample)
BR (1) BR6461527D0 (enExample)
CH (1) CH467266A (enExample)
DE (1) DE1470080A1 (enExample)
DK (4) DK108229C (enExample)
FR (1) FR1583154A (enExample)
GB (2) GB1077692A (enExample)
IL (2) IL21758A (enExample)
NL (2) NL139524B (enExample)
NO (1) NO116163B (enExample)
SE (1) SE325273B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022003986A1 (de) 2021-10-01 2023-04-06 Tobias Schmallenbach Multifunktionale Tasche

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3676439A (en) * 1971-04-13 1972-07-11 Hoffmann La Roche 5,6-dihydro-8,8-dimethyl-3-nitro-8h imidazo(2-1-c) (1,4)oxazine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022003986A1 (de) 2021-10-01 2023-04-06 Tobias Schmallenbach Multifunktionale Tasche

Also Published As

Publication number Publication date
FR1583154A (enExample) 1969-10-24
DK108153C (da) 1967-09-25
BR6461527D0 (pt) 1973-07-17
NL6409120A (enExample) 1965-02-08
NL139524A (enExample)
BE651423A (enExample) 1965-02-05
NL139524B (nl) 1973-08-15
DK109264C (da) 1968-04-08
GB1077696A (en) 1967-08-02
SE325273B (enExample) 1970-06-29
CH467266A (de) 1969-01-15
IL29324A (en) 1968-08-22
NO116163B (enExample) 1969-02-10
DK108499C (da) 1967-12-27
IL21758A (en) 1968-08-22
DK108229C (da) 1967-10-23
GB1077692A (en) 1967-08-02

Similar Documents

Publication Publication Date Title
DE1695093A1 (de) Neue Imidazolderivate
DE2706977A1 (de) Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
DE2147023C3 (de) Verfahren zur Herstellung von 1H- Tetrazol-Verbindungen
EP0017976A2 (de) Verfahren zur Herstellung von Imidazolidinderivaten
DE3442860A1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2052692A1 (de) Isothioharnstoffverbmdungen, ihre Salze mit Sauren, Verfahren zu ihrer Her stellung und ihre Verwendung zur Her stellung von Arzneimitteln
DE2410938A1 (de) Chinazolinderivate und diese enthaltende arzneimittel
DE1695133A1 (de) Verfahren zur Herstellung von Imidazolderivaten
DE1493181A1 (de) Verfahren zur Herstellung von 5 beta-Bisnorcholanderivaten
DE1670904A1 (de) Substituierte p-Hydroxyphenylhydrazone und Verfahren zu ihrer Herstellung
DE1470080A1 (de) 1-Niedrig-Alkyl-5-nitroimidazol-2-carboxamide,ein Verfahren zu ihrer Herstellung und ihre Verwendung als Heilmittel
DE1545978A1 (de) N-(4-Pyrimidinyl)-anthranilsaeuren und deren Derivate,sowie Verfahren zur Herstellung derselben
DE2319834A1 (de) Pyrazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE2456098C3 (de) Xanthen- und Thioxanthen-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1620016B2 (de) 3-(Piperazinoalkyl)-pyrazole und Verfahren zu ihrer Herstellung
DE2658762A1 (de) Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3438244A1 (de) 4-chlor-furo-(3,4-c)-pyridinderivate, verfahren zu ihrer herstellung und arzneimittel mit einem gehalt an diesen verbindungen
DE2708143C3 (de) 3-Carboxyphenylessigsäurederivate und Verfahren zu ihrer Herstellung
DE2137538A1 (de) Methoxyaminderivate und ihre Salze sowie ihre Verwendimg und Verfahren zur Herstellung derselben
DE1493567C3 (de) Ester von alpha-Alkylthyroxinderivaten und Verfahren zu ihrer Herstellung
DE1768366C3 (de) 3-Hydroxy-alpha-(l-aminoäthyl)benzylalkohol-derivate und diese enthaltende Arzneimittel
EP0054672A1 (de) Lactamverbindungen, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
DE69730615T2 (de) Verfahren zur herstellung eines tetrahydropyridinderivates
DE1695894A1 (de) Optisch aktive N-Acylproline und optisch aktives Prolin sowie Verfahren zu ihrer Herstellung
DE1670539C3 (de) Diacylthiamine und Verfahren zu deren Herstellung